Biotechnology Market is Projected To Grow Moderately at 7.4% CAGR from 2017 to 2025: Grand View Research Inc.

San Francisco, 5 March 2019: The Report Biotechnology Market Analysis By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing Bioinformatics), By Technology, And Segment Forecasts, 2018 - 2025

The global biotechnology market is expected to reach USD 727.1 billion by 2025, according to a new report by Grand View Research, Inc. The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent.

These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.

Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as UK and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months’ review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.

Access Research Report of Biotechnology Market@ www.grandviewresearch.com/industry-analysis/biotechnology-market

Further key findings from the report suggest:

·       Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period

·       Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market

·       Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues

·       North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share

·       Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years

·       Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products

·       Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine

·       Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the biotechnology market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Million; 2014 - 2025)

·         DNA Sequencing

·         Nanobiotechnology

·         Tissue engineering and Regeneration

·         Fermentation

·         Cell Based Assay

·         PCR Technology

·         Chromatography Market

·         Others

Biotechnology Application Outlook (Revenue, USD Million; 2014 - 2025)

·         Health

·         Food & Agriculture

·         Natural Resources & Environment

·         Industrial Processing

·         Bioinformatics

·         Others

Biotechnology Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa (MEA)

Access Press Release of Biotechnology Market@ www.grandviewresearch.com/press-release/global-biotechnology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Next Generation Sequencing Market Poised to Expand at a Robust Pace of USD 21.4 Billion Over 2025: Grand View Research Inc.

San Francisco, 5 March 2019: The Report Next Generation Sequencing (NGS) Market Size & Forecast By Application (Oncology, Reproductive Health), By Technology (Targeted, WGS, WES ), By Workflow (Data Analysis), By end-use (Academic & Clinical Research), And Trend Analysis, 2018 - 2025

The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing coverage of NGS is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting. Commercial payers are also engaged in reviewing the existing and novel tests in order to establish appropriate medical necessity criteria for their clinical and medical policies.

Moreover, improved understanding of the genetic markers of virulence and resistance provided by next generation sequencing is expected to drive demand of the technology in infectious disease diagnosis.

Access Research Report of Next Generation Sequencing Market @ www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market

Further Key Findings from the Report suggest:

·       Oncology accounted for the dominant share owing to phase-resolved and unambiguous results obtained by using single assay systems, and analysis program.

·       Targeted resequencing dominated the market owing to its associated benefits such as implementation of the technique such as lower turnaround time and more manageable data sets.

·       Academic usage of NGS accounted for the largest share with respect to market revenue by end uses and is anticipated to maintain its dominance.

·       Higher adoption of this technology and platforms in university projects is expected to support the estimated share.

·       Asia Pacific is estimated to witness the fastest growth over the forecast period owing to expected routing of a considerable portion of whole genome sequencing requirements herein.

·       Key players operating in the NGS market include Illumina Inc., Agilent Technologies, BGI, Pacific Biosciences, Qiagen, Roche, Thermo Fischer Scientific, and Oxford Nanopore Technologies Ltd.

·       Endeavors adopted by participants are such as acquisition of Enzymatics by Qiagen acquired solutions in order to enhance the product portfolio with respect to reagents needed in preparatory steps.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the NGS market on the basis of application, technology, workflow, and end use:

NGS Outlook, by Application (Revenue, USD Million; 2014 - 2025)

·         Reproductive Health

·         Oncology

·         HLA Typing/Immune System Monitoring

·         Metagenomics, Epidemiology & Drug Development

·         Agrigenomics & Forensics

·         Consumer Genomics

·         Clinical Investigation

NGS Outlook, by Technology (Revenue, USD Million; 2014 - 2025)

·         Targeted Sequencing Analysis

·         Whole Genome Sequencing

·         Whole Exome Sequencing 

NGS Outlook, by Workflow (Revenue, USD Million; 2014 - 2025)

·         Pre-sequencing

·         Sequencing

NGS Outlook, by End-use (Revenue, USD Million; 2014 - 2025)

·         Academic Research

·         Clinical Research

·         Hospitals & Clinics

·         Pharma & Biotech Entities

·         Other Users

NGS Outlook, by Region (Revenue, USD Million; 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Press Release of Next Generation Sequencing Market@ www.grandviewresearch.com/press-release/global-next-generation-sequencing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Plastic Compounding Market is Estimated To Expand at a CAGR of 6.7% through 2026: Grand View Research Inc.

San Francisco, 5 March 2019: The Report Plastic Compounding Market Analysis By Product (Polyethylene, Polypropylene, TPV, TPO, PVC, Polystyrene, PET, PBT, Polyamide, Polycarbonate, ABS), By Application, And Segment Forecasts, 2018 - 2026

The global plastic compounding market is expected to reach USD 95.2 billion by 2026, according to a new report by Grand View Research, Inc. Introduction of rapid manufacturing techniques & advanced additive incorporation methodologies is expected to further drive adoption of lightweight, high-performance plastics for production of several consumer products.

Plastics present a sustainable and low cost alternative to metals, wood and even ceramic materials utilized in varied industries. Rapid industrialization and expansion of said industries, including automotive, construction and electronics, specifically in emerging economies, is likely to influence consumption patterns & enhance demand over the forecast period.

An increasing number of R&D activities undertaken by key market participants, such as the recent introduction of FDA compliant polycarbonate grades by SABIC for high temperature food contact applications, are expected to revolutionize the sector. Other companies are expected to follow in SABIC’s wake, adopting sustainable and compliant manufacturing techniques to meet transitioning regulatory standards.

Polypropylene (PP) emerged as the dominant product with over 32% of the volume share in 2016. The segment is also expected to grow at a high CAGR of around 5% from 2017 to 2026, on account of its high utilization in the ever-expanding automotive industry. High impact resistance, ease of serviceability and light weight make this the material of choice for forming crucial automotive components such as bumpers, chemical tanks, gas cans, and others.

Access Research Report of Plastic Compounding Market@ www.grandviewresearch.com/industry-analysis/plastic-compounding-market

Further key findings from the report suggest:

·       The global plastic compounding market exceeded 26 million tons in 2016 and is expected to grow at a CAGR of 5.2% from 2016 to 2026

·       Polyethylene (PE) emerged as one of the dominant products owing to its high demand in medical applications and special performance characteristics that make it ideal for niche applications such as bulletproof vests

·       Thermoplastic vulcanizates (TPV) are expected to remain the fastest growing products with over 9% CAGR, witnessing high growth in the automotive & industrial machinery segments

·       Automotive is expected to retain its dominance in the industry; however, industrial machinery is expected to overtake the segment in terms of CAGR. The latter is increasingly adopting lightweight and sustainable plastic materials in the form of fasteners, films, equipment components and others.

·       Asia Pacific is likely to remain the dominant region with rapid industrialization in economies such as India, Vietnam, Thailand, Malaysia and others. The region benefits from close geographical proximity to European consumer markets, low labor costs and vast skilled workforce among other factors.

·       The industry is highly fragmented in nature with over one-third of market share occupied by SMEs engaged in plastic compounding. Kingfa emerged as a major player, followed by LyondellBasell and others such as BASF, PolyOne Corporation, SABIC, DuPont, A. Schulman, Mitsubishi Chemical Corporation, Bayer, China XD, Mitsui Chemicals and others.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the global plastic compounding market on the basis of product, application, and region:

Plastic Compounding Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2026)

·         Polyethylene

·         Polypropylene

·         TPV

·         TPO

·         PVC

·         Polystyrene

·         PET

·         PBT

·         Polyamide

·         Polycarbonate

·         ABS

·         Others

Plastic Compounding Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2026)

·         Automotive

·         Construction

·         Electrical & Electronics

·         Packaging

·         Consumer Goods

·         Industrial Machinery

·         Medical Devices

·         Optical Media

·         Others

Plastic Compounding Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2026)

·         North America

·         Europe

·         Asia Pacific

·         Central & South America

·         Middle East & Africa

Access Press Release of Plastic Compounding Market@ www.grandviewresearch.com/press-release/global-plastic-compounding-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com